Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT07501858Recruiting

Assessing the Association Between H. Pylori Persistence and the Severity of Insulin Resistance in Patients With Metabolic Syndrome

Role: collaborator

NCT04600544Completed

Russian Disc Degeneration Study

Role: lead

NCT03865355Completed

Blood and Cerebrospinal Fluid Metabolomic Profile in Glioma Patients

Role: lead

NCT05495516Unknown

Search for Methods to Predict the Development of Heart Failure After Myocardial Infarction

Role: collaborator

NCT05492084Completed

Personalized Risk of Rapidly Progressive Atherosclerosis

Role: collaborator

NCT05172362Unknown

Short-Term and Long-Term Cognitive Outcomes in Adults After Cardiac Surgery

Role: collaborator

NCT03931499Unknown

Biochemical Predictors of Delirium in Cardiac Surgery

Role: collaborator

All 7 trials loaded